Literature DB >> 24366823

Gated tomographic radionuclide angiography using cadmium-zinc-telluride detector gamma camera; comparison to traditional gamma cameras.

Maria Maj Jensen1, Ulla Schmidt, Chenxi Huang, Bo Zerahn.   

Abstract

PURPOSE: Estimation of left ventricular ejection fraction (LVEF) with equilibrium 99MTc-HSA equilibrium radionuclide angiography (MUGA) is frequently used for assessing cardiac function. The purpose of this study was to compare intra- and interobserver variation between three different gamma cameras.
MATERIALS AND METHODS: Eighty-two patients, scanned in the same sequential order on the three cameras. Each acquisition was analyzed twice by two technologists. Inter- and intraobserver variations were calculated as the coefficient of variation and the 95% confidence interval for limits of agreement between each sequence of analyses for each of the three cameras.
RESULTS: The lowest intraobserver variations in LVEF for the two NaI-detector cameras were 3.1% (-4.0% to 3.5%) for the planar and 3.4% (-4.2% to 4.5%) for SPECT (P ≤ 0.001-0.019), the highest result for the CZT SPECT camera was 2.6% (-2.9% to 3.1%). Similarly, interobserver variation was 4.8% (-4.8% to 6.4%) and 4.9% (-5.4% to 7.5%), respectively, for each of the NaI-detector cameras and 3.3% (-3.4% to 4.3%) for the CZT SPECT camera (P ≤ 0.001-0.008). DISCUSSION: The CZT detector camera was superior to both NaI detector cameras regarding intra- and interobserver variation. The CZT SPECT camera may identify changes in LVEF with greater certainty than its NaI detector-equipped counterparts.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24366823     DOI: 10.1007/s12350-013-9844-6

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  23 in total

Review 1.  Measuring agreement in method comparison studies.

Authors:  J M Bland; D G Altman
Journal:  Stat Methods Med Res       Date:  1999-06       Impact factor: 3.021

2.  Planar imaging versus gated blood-pool SPECT for the assessment of ventricular performance: a multicenter study.

Authors:  M W Groch; E G DePuey; A C Belzberg; W D Erwin; M Kamran; C A Barnett; R C Hendel; S M Spies; A Ali; R C Marshall
Journal:  J Nucl Med       Date:  2001-12       Impact factor: 10.057

3.  Left ventricular ejection fraction and volumes from gated blood-pool SPECT: comparison with planar gated blood-pool imaging and assessment of repeatability in patients with heart failure.

Authors:  Graham A Wright; Simon Thackray; Syd Howey; John G Cleland
Journal:  J Nucl Med       Date:  2003-04       Impact factor: 10.057

4.  Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging.

Authors:  Jonathan Walker; Navdeep Bhullar; Nazanin Fallah-Rad; Matthew Lytwyn; Mehrdad Golian; Tielan Fang; Arthur R Summers; Pawan K Singal; Ivan Barac; Iain D Kirkpatrick; Davinder S Jassal
Journal:  J Clin Oncol       Date:  2010-06-07       Impact factor: 44.544

5.  Commentary: Current issues in nuclear cardiology.

Authors:  C M Tonge; R C Fernandez; M T Harbinson
Journal:  Br J Radiol       Date:  2008-02-04       Impact factor: 3.039

6.  Assessment of poststress left ventricular ejection fraction by gated SPECT: comparison with equilibrium radionuclide angiocardiography.

Authors:  Wanda Acampa; Maria Grazia Caprio; Emanuele Nicolai; Raffaele Liuzzi; Serena De Luca; Enza Capasso; Luca Luongo; Mario Petretta; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-01       Impact factor: 9.236

7.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

8.  A prospective comparison of cardiac magnetic resonance imaging and radionuclide ventriculography in the assessment of cardiac function in patients treated with anthracycline-based chemotherapy.

Authors:  Petri Sipola; Sipola Petri; Esko Vanninen; Vanninen Esko; Esa Jantunen; Jantunen Esa; Tapio Nousiainen; Nousiainen Tapio; Mikko Kiviniemi; Kiviniemi Mikko; Juha Hartikainen; Hartikainen Juha; Taru Kuittinen; Kuittinen Taru
Journal:  Nucl Med Commun       Date:  2012-01       Impact factor: 1.690

9.  Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography.

Authors:  R G Schwartz; W B McKenzie; J Alexander; P Sager; A D'Souza; A Manatunga; P E Schwartz; H J Berger; J Setaro; L Surkin
Journal:  Am J Med       Date:  1987-06       Impact factor: 4.965

10.  Compared performance of high-sensitivity cameras dedicated to myocardial perfusion SPECT: a comprehensive analysis of phantom and human images.

Authors:  Laetitia Imbert; Sylvain Poussier; Philippe R Franken; Bernard Songy; Antoine Verger; Olivier Morel; Didier Wolf; Alain Noel; Gilles Karcher; Pierre-Yves Marie
Journal:  J Nucl Med       Date:  2012-11-08       Impact factor: 10.057

View more
  17 in total

1.  Left ventricular ejection fraction determined with the simulation of a very low-dose CZT-SPECT protocol and an additional count-calibration on planar radionuclide angiographic data.

Authors:  Hubert Tissot; Véronique Roch; Olivier Morel; Nicolas Veran; Mathieu Perrin; Marine Claudin; Antoine Verger; Gilles Karcher; Pierre-Yves Marie; Laetitia Imbert
Journal:  J Nucl Cardiol       Date:  2019-02-27       Impact factor: 5.952

2.  Proposed volume-based methods for correcting the shift in left ventricular ejection fraction from blood-pool gated SPECT.

Authors:  Pierre-Yves Marie; Laetitia Imbert
Journal:  J Nucl Cardiol       Date:  2019-02-19       Impact factor: 5.952

3.  Applying a correction factor to gated blood pool SPECT left ejection fraction value: Can this approach be used to get around a longstanding hurdle?

Authors:  Sylvain Prévost; Etienne Rousseau
Journal:  J Nucl Cardiol       Date:  2019-03-04       Impact factor: 5.952

4.  Utility of reprojected tomograms.

Authors:  Kenneth J Nichols; Andrew Van Tosh
Journal:  J Nucl Cardiol       Date:  2014-07-26       Impact factor: 5.952

5.  Which SPECT for today, which SPECT for tomorrow?

Authors:  Milena J Henzlova; W Lane Duvall
Journal:  J Nucl Cardiol       Date:  2016-04-12       Impact factor: 5.952

6.  Comparison of biventricular ejection fractions using cadmium-zinc-telluride SPECT and planar equilibrium radionuclide angiography.

Authors:  Yi-Chieh Chen; Chi-Lun Ko; Rouh-Fang Yen; Mei-Fang Lo; Yih-Hwen Huang; Pei-Ying Hsu; Yen-Wen Wu; Mei-Fang Cheng
Journal:  J Nucl Cardiol       Date:  2016-03-08       Impact factor: 5.952

7.  Assessment of an intermediate reprojection technique transitioning from planar to SPECT radionuclide ventriculography.

Authors:  Jim O'Doherty; Bruno Rojas Fisher; Jonathan Mark Price; Kshama Wechalekar
Journal:  J Nucl Cardiol       Date:  2014-08-01       Impact factor: 5.952

8.  Pre-chemotherapy values for left and right ventricular volumes and ejection fraction by gated tomographic radionuclide angiography using a cadmium-zinc-telluride detector gamma camera.

Authors:  Christian Haarmark; Christine Haase; Maria Maj Jensen; Bo Zerahn
Journal:  J Nucl Cardiol       Date:  2015-09-04       Impact factor: 5.952

9.  Adopting new gamma cameras and reconstruction algorithms: Do we need to re-establish normal reference values?

Authors:  Timothy L Miao; Vinay Kansal; R Glenn Wells; Iftikhar Ali; Terrence D Ruddy; Benjamin J W Chow
Journal:  J Nucl Cardiol       Date:  2015-08-25       Impact factor: 5.952

Review 10.  Performance of cardiac cadmium-zinc-telluride gamma camera imaging in coronary artery disease: a review from the cardiovascular committee of the European Association of Nuclear Medicine (EANM).

Authors:  Denis Agostini; Pierre-Yves Marie; Simona Ben-Haim; François Rouzet; Bernard Songy; Alessandro Giordano; Alessia Gimelli; Fabien Hyafil; Roberto Sciagrà; Jan Bucerius; Hein J Verberne; Riemer H J A Slart; Oliver Lindner; Christopher Übleis; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-19       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.